Skip to main content
OpenTrials
Completed

NCT Number: NCT00632554

The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia

A comparison of 3 months-prednisolone administration with 6 months-prednisolone therapy in the treatment of chronic eosinophilic pneumonia. Three months-prednisolone administration may be as effective as 6 months-therapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Eosinophilic Pneumonia Chronic Disease Disease Attributes Eosinophilia Hematologic Diseases Hemic and Lymphatic Diseases Hypereosinophilic Syndrome Leukocyte Disorders Lung Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Eosinophilia Respiratory Tract Diseases

Age range

16 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Hamamatsu University School of Medicine

Hamamatsu, Japan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Biopsy-proven chronic eosinophilic pneumonia

Exclusion criteria

  • Patients who received oral glucocorticosteroid (more than 10 mg)
  • Immunosuppressive drug

Treatment and study plan

prednisolone 0.5 mg/kg/day for three months

Drug

period of treatment

Other names: prednisolone

prednisolone 0.5 mg/kg/day for six months

Drug

period of therapy

Other names: prednisolone

Primary outcomes

  1. Efficacy of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia

    Time frame: Three years

Secondary outcomes

  1. Safety of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia

    Time frame: Three years

Sponsors and collaborators

Lead sponsor

Hamamatsu University

Other

Registry information

Official study title

Phase 4, Randomized Study of Three Months-prednisolone Therapy in the Treatment of Chronic Eosinophilic Pneumonia

Important dates

Study start
2008
Primary completion
2010
Study completion
2010
First posted
Mar 10, 2008
Registry last updated
Sep 19, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.